• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    S

    Shanghai Cancer Center

    58论文总数
    1,144引用总数

    The Fudan University Shanghai Cancer Center (FUSCC, Chinese: 复旦大学附属肿瘤医院), also called the Shanghai Cancer Hospital (Chinese: 上海市肿瘤医院), is a teaching hospital affiliated with the Shanghai Medical College of Fudan University. Founded in 1931, it is the first cancer specialty hospital in China. It is rated Grade 3, Class A.

    论文量&引用量时间轴

    机构学者

    排序
    Dingwei Ye
    Dingwei Ye
    Institutes of Biomedical Sciences, Fudan University;Fudan University Shanghai Cancer Center
    论文:5引用:0H-index:0
    Zhimin Shao
    Zhimin Shao
    Fudan University Shanghai Cancer Center;Institutes of Biomedical Sciences, Fudan University;Fudan University Cancer Institute;Breast Cancer Research Institute, Fudan University
    论文:5引用:0H-index:0
    Keda Yu
    Keda Yu
    Fudan University Shanghai Cancer Center
    论文:3引用:0H-index:0
    Wentao Yang
    Wentao Yang
    Department ofRadiology, The Affiliated Cancer Hospital of Fudan University, Department of Oncology, Shanghai MedicalCollege, Fudan University
    论文:3引用:0H-index:0
    Genhong Di
    Genhong Di
    Shanghai Cancer Center, Fudan University
    论文:3引用:0H-index:0
    Jiong Wu
    Jiong Wu
    Department of Breast Surgery, Fudan University Shanghai Cancer Center
    论文:3引用:0H-index:0
    Meili Sun
    Meili Sun
    Jinan Central Hospital, Shandong University
    论文:2引用:0H-index:0
    Xianjun Yu
    Xianjun Yu
    Fudan University Cancer Institute;Department of Breast Surgery, Fudan University Shanghai Cancer Center
    论文:2引用:0H-index:0
    Zhenzhou Shen
    Zhenzhou Shen
    Fudan University Shanghai Cancer Center
    论文:2引用:0H-index:0

    论文(59)

    年份
    起
    –
    止
    排序
    1CV43. Uniportal VATS Septum Guided LS(1+2)a Resection
    Junfeng Geng, Qing Wang, Zhexu Wen, Yaofei Pei, Xinshu Wu, Shuai Xiao,Zhigang Li
    2026The Journal of Thoracic and Cardiovascular Surgery(2026)
    引用
    AI阅读
    加入学术空间
    2CV44. Uniportal VATS Septum Guided LS3 Resection
    Junfeng Geng, Qing Wang, Zhexu Wen,Yaofei Pei, Xinshu Wu, Shuai Xiao,Zhigang Li
    2026The Journal of Thoracic and Cardiovascular Surgery(2026)
    引用
    AI阅读
    加入学术空间
    3Lactate-induced Mir-7-5p/trim33 Reprograms Metabolic Flux to Suppress Tumor Growth and Viral Reactivation.
    Yifei Xu, Xuehua Min, Zihan Zhang, Yulin Zhang,Xiaoting Chen, Xinyu Wang,Caixia Zhu, Erle Robertson, Qunling Zhang,Yin Tong,Liming Zhang,Yuyan Wang,

    Cancer metabolic reprogramming generates a hostile tumor microenvironment (TME) characterized by lactate-driven acidosis, fostering tumor progression. Epstein-Barr virus (EBV), an oncogenic herpesvirus linked to multiple malignancies, thrives under such stress, yet how it interacts with and contributes to an acidic TME remains poorly understood. Here, we identify miR-7-5p as a lactate-downregulated microRNA with diagnostic potential in plasma from patients with EBV-associated diffuse large B cell lymphoma and nasopharyngeal carcinoma. TRIM33, a previously uncharacterized lactate-inducible transcriptional regulator of glycolytic flux, is directly targeted by miR-7-5p. Integrative multi-omics analyses reveal that lactate promotes TRIM33 binding to specific motifs in the promoters of key glycolytic genes, including SLC16A1, which enhances their expression and reprograms metabolism. Importantly, the loss of TRIM33 accelerates tumor growth, enhances EBV reactivation, and confers resistance to lactate-transporter inhibitors. Our finding provides circulating miR-7-5p as a noninvasive biomarker and reveals TRIM33 as an integrator of lactate stress, metabolism, and viral oncogenesis, offering a novel dual-targeting therapeutic strategy.

    2026Molecular therapy the journal of the American Society of Gene Therapy(2026)
    引用
    AI阅读
    加入学术空间
    41211 the Role of the LMP2A/PKCδ/IκBε Axis in Immune Evasion of EBV-Associated Large B-Cell Lymphoma and Development of a Diagnostic-Therapeutic Model
    Xiang-Nan Jiang,Xiaoqiu Li
    2026Laboratory Investigation(2026)
    引用
    AI阅读
    加入学术空间
    5Integrated Molecular Characterization of ALK-Positive Large B-Cell Lymphoma: A Distinct Entity Defined by Epigenetic Dysregulation and Signaling Pathway Heterogeneity
    Xiang-Nan Jiang,Xiaoqiu Li
    2026LABORATORY INVESTIGATION(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 59 篇论文

    合作机构(100)

    复旦大学合作论文 16
    上海交通大学合作论文 8
    浙江省肿瘤医院合作论文 3
    多伦多大学健康网络合作论文 2
    瑪嘉烈醫院合作论文 2
    江西省肿瘤医院合作论文 2
    中山大学合作论文 2
    北京大学肿瘤医院合作论文 2
    香港中文大学合作论文 2
    淄博市中心医院合作论文 2

    机构统计